| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
0.025 |
0.9 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.008 |
0.9 |
| mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |